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In human platelets, the Ca 2f ionophore A23187 stimulated the phosphorylation of a 40 kDa protein and 
myosin light chain (MLC) to the same extents as those induced by thrombin, but the doses of A23187 for 
40 kDa protein phosphorylation were higher than those for MLC phosphorylation, although the doses of 
thrombin for both reactions were nearly the same. Moreover, A23187 produced much less diacylglycerol 
than thrombin. However, the sites of the 40 kDa protein phosphorylated by the action of A23187 and 
thrombin were identical, and the 40 kDa protein phosphorylation induced by A23187 and thrombin was 
inhibited by tetracaine, an inhibitor for protein kinase C. Neither A23 187 nor thrombin induced the produc- 
tion of a catalytic fragment of protein kinase C which might be generated by limited proteolysis with CaZ+- 
dependent protease. These results indicate that A23187 induces protein kinase C activation which phosphor- 
ylates the 40 kDa protein, but higher doses of A23187 are required for the activation of this enzyme than 
for the activation of MLC kinase. 
Platelet Caz+ ionophore Protein kinase C Protein phosphorylation Diacylglycerol Cytoplasmic Ca2+ 
1. INTRODUCTION 
Platelet aggregation and release reaction are 
elicited in response to many agonists including 
thrombin, collagen and PAF (review [l]). The 
modes of action of these agonists have been in- 
vestigated extensively, and protein phosphoryla- 
tion, particularly the phosphorylation of a 40 kDa 
protein and MLC, has been demonstrated to be in- 
volved in release reaction from platelets [2,3]. 
MLC and the 40 kDa protein are phosphorylated 
by MLC kinase and protein kinase C, respectively, 
during the action of thrombin, collagen and PAF 
[4-71. MLC kinase is activated by Ca2+ in a 
calmodulin-dependent manner [8]. Protein kinase 
Abbreviations: PAF, platelet-activating factor; MLC, 
myosin light chain 
C is activated in 2 diff ?ent manners as far as 
tested in a cell-free syste _: proteolytic activation 
by Ca2+-dependent protease [9,10] and non- 
proteolytic activation by diacylglycerol and Ca2+ 
in the presence of membrane phospholipid 
[I I-131. The diacylglycerol is derived from 
phosphoinositide turnover which is induced by the 
agonists described above in a receptor-linked man- 
ner [5-71. 
The Ca2+ ionophore A23 187 is also known to in- 
duce platelet aggregation and release reaction [ 141. 
This agonist stimulates the phosphorylation of the 
40 kDa protein as well as MLC to the same extent 
as that induced by other agonists described above 
[3]. However, it has not been clarified which pro- 
tein kinase is involved in A23187-induced 
phosphorylation of the 40 kDa protein. Further- 
more, Rittenhouse-Simmons [15] has reported that 
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A23187 produces much less diacylglycerol than 
thrombin. It has also been reported that 
Ca’+-dependent proteolysis occurs during stimula- 
tion of platelets with A23187 [ 161. Therefore, we 
attempted to identify the enzyme which is responsi- 
ble for A23 187-induced 40 kDa protein 
phosphorylation and to compare the mode of ac- 
tion of A23187 with that of thrombin. 
2. MATERIALS AND METHODS 
2.1. Materials and chemicals 
Washed human platelets were prepared by the 
method of Baenziger and Majerus [ 171. Carrier- 
free 32Pi and [3H]arachidonic acid (78.2 Ci/mmol) 
were purchased from Japan Radioisotope Associa- 
tion and New England Nuclear, respectively. 
[Y-~~P]ATP was prepared by the method of Glynn 
and Chappell [18]. Bovine thrombin and A23 187 
were the products of Mochida Pharmaceutical and 
Calbiochem, respectively. Tetracaine hydrochlo- 
ride was donated by Kyorin Pharmaceutical. Calf 
thymus Hl histone was prepared as described [9]. 
A mixture of phospholipids was extracted from 
bovine brain and fractionated on a silicic acid col- 
umn as in [ 111. Other materials and chemicals were 
obtained from commercial sources. 
2.2. Preparation and stimulation of platelets 
The platelets were prelabelled with either 32Pi or 
[3H]arachidonic acid according to Lyons et al. [2] 
and Rittenhouse-Simmons [ 191, respectively. The 
radioactive platelets were then stimulated by either 
thrombin or A23187 as indicated in each experi- 
ment. The radioactive lipids were directly extracted 
from the platelets by the method of Bligh and Dyer 
[20], and subjected to thin-layer chromatography 
on a silica gel G plate using a solvent system of 
benzene/diethyl ether/ethanol/NI%OH (50: 40: 
2: 0.1) for separating diacylglycerol [19], or 
chloroform/methanol/acetic acid/water (25 : 15 : 
4 : 2) for separating phospholipids [21]. Radioac- 
tive platelet proteins were directly subjected to 
SDS-slab gel electrophoresis, stained, dried on 
filter paper, and then exposed to an X-ray film to 
prepare an autoradiograph as described in [5]. 
Electrophoresis was carried out by the method of 
Laemmli [22]. The relative intensity of each band 
was quantitated by densitometric tracing of the 
autoradiograph using a Shimadzu model CS-910 
dual-wavelength chromatogram scanner. Two- 
dimensional mapping of tryptic peptides from the 
radioactive 40 kDa protein recovered from SDS- 
polyacrylamide gel was performed as in [6]. 
2.3. Assay for protein kinase C 
Protein kinase C was assayed in a reaction mix- 
ture (0.25 ml) containing 5 pmol Tris-HCl at pH 
7.5, 1.25 pmol magnesium acetate, 5Opg Hl 
histone, 2.5 nmol [T-~~P]ATP (1 x lo5 cpm/ 
nmol), 225 nmol CaC12, 1Opg phospholipid, 
0.2 fig diolein and an enzyme preparation. Where 
indicated, 0.5 rmol EGTA was added instead of 
diolein, Ca2+ and phospholipid. After the reaction 
was carried out for 3 min at 30°C the acid- 
precipitable radioactivity was determined as 
described [9]. 
3. RESULTS 
When platelets were incubated with various 
doses of either thrombin or A23187, the 40 kDa 
l- 
Fig.1. Dose-response curves for A23187- and thrombin- 
induced diacylgfycerol formation, 40 kDa protein 
phosphorylation and MLC phosphorylation. The 
platelets, which were labelled with [3H]arachidonic acid 
or 32Pi, were stimulated by various doses of either 
A23 187 or thrombin. The incubation was carried out for 
15 s at 37°C to measure diacylglycerol formation, and 
for 1 min to measure protein phosphorylation. Other 
details are described in section 2. (A) Stimulated by 
thrombin, (B) stimulated by A23187. (S) 
Diacylglycerol formation, (o---o) 40 kDa protein 
phosphorylation, ( w-+) MLC phosphorylation. Each 
value is the mean of triplicate determinations. 40K 
protein, 40 kDa protein. 
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protein and MLC were phosphorylated in a dose- 
dependent manner as shown in fig.1. The max- 
imum levels of the 40 kDa protein and MLC 
phosphorylation induced by thrombin and A23 187 
were nearly the same. However, the doses of 
A23 187 for 40 kDa protein phosphorylation were 
higher than those for MLC phosphorylation, 
whereas the doses of thrombin for both reactions 
were roughly equal. Moreover, A23187 produced 
much less diacylglycerol than thrombin. The doses 
of A23 187 for diacylglycerol formation were again 
higher than those for MLC phosphorylation, 
whereas the doses of thrombin for both reactions 
were nearly the same. This small formation of 
diacylglycerol during the action of A23 187 was not 
simply due to its rapid conversion to phosphatidic 
acid via the pathway of phosphoinositide turnover, 
nor to its degradation to monoacylglycerol and 
free fatty acid by the action of diacylglycerol 
lipase, since A23 187 did not stimulate 32P incor- 
poration into phosphatidic acid nor inhibit the 
thrombin-induced reaction (not shown). 
In spite of these differences in the actions of 
thrombin and A23187, the sites of the 40 kDa pro- 
tein phosphorylated by the action of these 2 
agonists were identical as judged by fingerprint 
analysis as shown in fig.2. Moreover, A23187- as 
well as thrombin-induced 40 kDa protein 
phosphorylation was markedly inhibited by tetra- 
Caine, an inhibitor for protein kinase C [23], as 
shown in table 1. Under similar conditions, this 
drug did not inhibit A23187- and thrombin- 
induced diacylglycerol formation. These results 
strongly suggest hat the same protein kinase is in- 
volved in both A23187- and thrombin-induced 
40 kDa protein phosphorylation. Since protein 
kinase C has been demonstrated to be responsible 
for thrombin-induced 40 kDa protein phosphory- 
lation [5,6], it is most likely that the same enzyme 
is also involved in A23187-induced phosphoryla- 
tion of this protein. 
In the last set of experiments, we investigated 
whether protein kinase C is activated in a pro- 
teolytic or non-proteolytic manner during the ac- 
tion of A23187 and thrombin. After stimulation 
with A23187 platelets were disrupted and cen- 
trifuged. The enzymatic activities of protein kinase 
C in the soluble and particulate fractions were then 
assayed. Most of the protein kinase C activity was 
found in the soluble fraction and the enzymatic ac- 
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Fig.2. Autoradiographs of tryptic digests of the 40 kDa 
protein phosphorylated in platelets during the action of 
A23187 and thrombin. The phosphorylation of the 
40 kDa protein was carried out as described in the legend 
to fig.1. The radioactive 40 kDa protein was extracted 
from the gel, digested with trypsin, and subjected to 
cellulose coated thin-layer plate electrophoresis in the 
horizontal dimension (negative pole left, positive pole 
right) followed by ascending chromatography in the 
vertical dimension as described [6]. Arrowheads indicate 
the origin. (A) Stimulated by thrombin, (B) stimulated 
by A23187. 
tivity in the soluble fraction was dependent on 
diacylglycerol, Ca2+ and phospholipid as shown in 
table 2. The catalytic fragment of protein kinase C, 
which was fully active even without these ac- 
tivators and might be produced by limited pro- 
teolysis with Ca2+-dependent protease, could not 
be detected. Similar results were obtained for the 
platelets stimulated by thrombin. These results in- 
dicate that protein kinase C is activated in a non- 
proteolytic manner during the action of A23 187 as 
well as of thrombin. 
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Table 1 4. DISCUSSION 
Effects of tetracaine on A23187- and thrombin-induced 
diacylglycerol formation and 40 kDa protein 
phosphorylation 
It is well established that protein kinase C is ac- 
tivated by Ca*+, diacylglycerol and phospholipid 
[ 1 l-131. Kinetic studies in a cell-free system have 
revealed that Ca*+ and phospholipid are essential 
for the activation of the enzyme and that 
diacylglycerol increases the affinity of the enzyme 
for Ca*+ [12,13]. Therefore, it is conceivable that 
protein kinase C can be activated by either 
diacylglycerol formation, Ca*+ increase or both in 
intact cells. The present results indicate that 
A23187 elicits the full activation of protein kinase 
C but does not induce diacylglycerol formation to 
a great extent compared with thrombin. Moreover, 
the doses of A23 187 for protein kinase C activa- 
tion are higher than those for MLC kinase activa- 
tion, whereas the doses of thrombin for the activa- 
tion of both enzymes are nearly the same. Since 
MLC kinase is activated in proportion to an in- 
crease of cytoplasmic free Ca*+ concentrations 
[24], our results strongly suggest hat, during the 
action of A23187, protein kinase C is activated at 
Ca*+ concentrations higher than those necessary 
for the activation of MLC kinase, whereas, during 
the action of thrombin, protein kinase C is ac- 
tivated at the Ca*+ concentrations nearly the same 
as those necessary for the activation of MLC 
kinase. It is likely that diacylglycerol produced by 
the action of A23 187 is not enough to decrease the 
Ca*+ concentrations to the levels at which MLC 
kinase is fully activated, and that protein kinase C 
may be activated by relatively higher concentra- 
tions of Ca*+ in the presence of a small amount of 
diacylglycerol. 
Treatment Diacylglycerol 40 kDa 
formation protein 
(cpm) phosphoryl- 
ation G4430~d 
None 80 0.18 
A23187 380 0.60 
A23187 + tetracaine 350 0.39 
Thrombin 1320 0.72 
Thrombin + tetracaine 1360 0.38 
Tetracaine 70 0.18 
The platelets, which were labelled with [3H]arachidonic 
acid or “Pi, were incubated with tetracaine (2 mM) for 
2 min at 37”C, and then stimulated by either A23187 
(2rM) or thrombin (1 unit/ml) under the conditions 
described in the legend to fig.1. Each value is the mean 
of triplicate determinations 
Table 2 
Non-proteolytic activation of protein kinase C during 
the action of A23187 and thrombin 
Treatment Protein kinase activity 
With diolein, CaClz With EGTA 
and phospholipid 
None 8720 1110 
A23187 9050 1220 
Thrombin 8860 1180 
Platelets (5 x 10’ cells) were stimulated by either A23187 
(2pM) or thrombin (1 unit/ml) for 3 min at 37”C, 
cooled.on ice and then centrifuged at 8750 x g for 1 min. 
The platelets were suspended in 1 ml of 20 mM Tris-HCl 
at pH 7.5 containing 0.25 M sucrose, 10 mM 
2-mercaptoethanol, 2 mM EDTA, 5 mM EGTA and 
2 mM phenylmethylsulfonyl fluoride, and then 
disrupted by sonication using a Kontes Micro-ultrasonic 
cell disrupter. The homogenate was centrifuged for 
60 min at 100000 x g. The supernatant (20~1) was 
assayed for protein kinase C activity under the 
conditions described in section 2. Each value (in cpm) is 
the mean of triplicate determinations 
In conclusion, A23187 as well as thrombin in- 
duces protein kinase C activation which then 
phosphorylates the 40 kDa protein, but the modes 
of activation of this enzyme during the action of 
these agonists are slightly different. 
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